title: Effect of dietary insoluble fiber on control of glycemia in cats with naturally acquired diabetes mellitus.
abstract: OBJECTIVE
  To evaluate effects of dietary insoluble fiber on control of glycemia in cats with naturally acquired diabetes mellitus.
  
  
  METHODS
  Randomized controlled crossover trial.
  
  
  METHODS
  16 cats with naturally acquired diabetes mellitus.
  
  
  METHODS
  Cats were fed a diet high in insoluble fiber (HF) containing 12% cellulose (dry-matter basis) or a diet low in insoluble fiber (LF) for 24 weeks; they were fed the other diet for the subsequent 24 weeks. Caloric intake and insulin treatment were adjusted to maintain stable body weight and control of glycemia, respectively. Cats were allowed an adaptation period of 6 weeks after initiation of a diet, after which control of glycemia was evaluated at 6-week intervals for 18 weeks. Variables assessed included serum glucose concentration measured during the preprandial state, blood glycated hemoglobin concentration, serum glucose concentration measured at 2-hour intervals for 12 hours beginning at the time of the morning insulin injection, 12-hour mean serum glucose concentration, and mean fluctuation in serum glucose concentration from the 12-hour mean serum glucose concentration.
  
  
  RESULTS
  Mean daily caloric intake, body weight, or daily insulin dosage did not differ significantly between cats when fed HF and LF diets. Mean preprandial serum glucose concentration, most post-prandial serum glucose concentrations, and the 12-hour mean serum glucose concentration were significantly lower when cats consumed the HF diet, compared with values when cats consumed the LF diet.
  
  
  CONCLUSIONS
  These results support feeding a commercially available diet containing approximately 12% insoluble fiber (dry-matter basis) to cats with naturally acquired diabetes mellitus.
authors.affiliation: Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616, USA.
authors.forename: R W
authors.initials: RW
authors.lastname: Nelson
authors.forename: J C
authors.initials: JC
authors.lastname: Scott-Moncrieff
authors.forename: E C
authors.initials: EC
authors.lastname: Feldman
authors.forename: S E
authors.initials: SE
authors.lastname: DeVries-Concannon
authors.forename: P H
authors.initials: PH
authors.lastname: Kass
authors.forename: D J
authors.initials: DJ
authors.lastname: Davenport
authors.forename: C T
authors.initials: CT
authors.lastname: Kiernan
authors.forename: L A
authors.initials: LA
authors.lastname: Neal
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D002371:Cat Diseases / Q000097:blood / Q000178:diet therapy*; D002415:Cats; D018592:Cross-Over Studies; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000178:diet therapy / Q000662:veterinary*; D004043:Dietary Fiber / Q000627:therapeutic use*; D005260:Female; D008297:Male; D012995:Solubility
chemical_list: D001786:Blood Glucose; D004043:Dietary Fiber